Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors. - Wikidata - wikimedia - TriplyDB

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

http://www.wikidata.org/entity/Q33402705

about

Targeted antiangiogenic agents in combination with cytotoxic chemotherapy in preclinical and clinical studies in sarcoma Sunitinib in combination with gemcitabine for advanced solid tumours: a phase I dose-finding study.A case of metastatic renal cell carcinoma and bile duct carcinoma treated with a combination of sunitinib and gemcitabine.Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer.The potential of sunitinib as a therapy in ovarian cancer.Anti-angiogenesis target therapy for advanced osteosarcoma (Review).A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors.

P2860

Q26747666-10EEC146-7651-4EE0-B943-09AF55FEA07C Q33406542-542E81D0-4BF3-4592-B37D-D8DC917D859D Q35639659-372E6705-CBEC-4270-BE0A-0F6429F0CDF2 Q36505652-ED69B57D-DDB1-4218-B8B7-6E166DEDD426 Q38144166-48FDEC88-4797-4505-98D7-93CB2DEF96D7 Q39401628-F7A6EC11-B004-4A04-BA11-98F4239926B2 Q51592896-EA46F84D-158E-4284-9257-7CAE6689D499

P2860

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

http://www.wikidata.org/entity/Q33402705

description

2012 nî lūn-bûn

@nan

2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

@ast

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

@en

type

label

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

@ast

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

@en

prefLabel

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

@ast

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

@en

P1433

Q33402705-6D9B9FF1-0ECD-420E-944C-90BAE7530C23

P1476

Q33402705-125EC9B3-C4A9-440E-9D5E-2766B2CF059C

P2093

Q33402705-24C1C6DF-819A-4D89-A2AB-ED324753170E

Q33402705-3361CAA6-C165-493A-9C72-D8E8EC54271D

Q33402705-3AD0A8EA-FAAF-4D4A-811F-A85512E4D27C

Q33402705-45A7DE0B-8528-4DA9-A942-3689004EF563

Q33402705-67C16F0A-1337-4684-9808-8A904C69024F

Q33402705-A7C63078-1E5C-4E9A-B77A-4A7617F85A78

Q33402705-B0AB38D7-F234-49A3-BEF8-BCB3AD351465

Q33402705-C2C47BED-82F0-4AAE-9CEA-57F608A12F99

Q33402705-F094E61D-7DF4-43FF-B024-4EA91AE69006

Q33402705-F63A504B-9BCA-43D6-9703-8B9EA8FA9B43

P2860

Q33402705-10DA4A96-4800-4D30-870D-E938E43ED95A

Q33402705-2B2EE0B4-6650-4A09-8281-08100D16AD54

Q33402705-3827EAC6-5DB5-4EE4-B75A-6475A7C4FFE5

Q33402705-4424DD39-CD89-4843-97BF-392E5D1A9D52

Q33402705-539F7D76-6B5F-423F-AC03-94D75743B376

Q33402705-57CDDCD5-AFDB-4563-ACEB-A35573569BB2

Q33402705-653E118B-C23F-4D0A-8048-C0B34603775F

Q33402705-95660B50-0B3D-483E-B3C6-C4EAF7CA0AC6

Q33402705-9D43B995-B855-464C-B692-D009957101B9

Q33402705-A47BB04B-9F40-4A29-A54E-4AE889E28CF6

P2888

Q33402705-2181578F-0FD5-4080-9FE4-D39AB1D4F85D

P304

Q33402705-6B68EBBB-311E-4287-8692-574B72F01E7E

P31

Q33402705-D97D8473-8740-49EA-BCCC-AA9F8A2A365C

P356

Q33402705-17AA971C-57E4-4CA0-9430-8026880883F4

P433

Q33402705-B497EEBB-4942-4382-B2B7-F182A23600B2

P478

Q33402705-D92B7138-4E31-4F3B-B681-BFBD75A6CDEC

P577

Q33402705-C772BD9D-52A8-462C-BDBD-C220AA93EEF6

P6179

Q33402705-4AF54216-D2BF-400E-B4A8-E1708F70A15C

P698

Q33402705-72D88F22-779A-4660-BAD4-609FCEF868D6

P921

Q33402705-20E16E36-CBA1-4612-B12C-AD6755A6C3EF

P932

Q33402705-4144011D-04DC-4A71-B79D-8C19A0CDA05B

P356

S00280-012-1936-5

P1433

Cancer Chemotherapy and Pharmacology

P1476

Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors.

@en

P2093

Afshin Dowlati

http://www.w3.org/2001/XMLSchema#string

Joanna M Brell

http://www.w3.org/2001/XMLSchema#string

Joseph A Bokar

http://www.w3.org/2001/XMLSchema#string

Joseph Gibbons

http://www.w3.org/2001/XMLSchema#string

Linda Rath

http://www.w3.org/2001/XMLSchema#string

Matthew M Cooney

http://www.w3.org/2001/XMLSchema#string

Neal J Meropol

http://www.w3.org/2001/XMLSchema#string

Panayiotis Savvides

http://www.w3.org/2001/XMLSchema#string

Percy Ivy

http://www.w3.org/2001/XMLSchema#string

Smitha S Krishnamurthi

http://www.w3.org/2001/XMLSchema#string

P2860

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

Addition of gemcitabine at the time of sunitinib resistance in metastatic renal cell cancer.

Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205

Gemcitabine plus bevacizumab compared with gemcitabine plus placebo in patients with advanced pancreatic cancer: phase III trial of the Cancer and Leukemia Group B (CALGB 80303).

Sunitinib malate synergistically potentiates anti-tumor effect of gemcitabine in human bladder cancer cells.

Antitumour activity of sunitinib in combination with gemcitabine in experimental pancreatic cancer

Metronomic gemcitabine in combination with sunitinib inhibits multisite metastasis and increases survival in an orthotopic model of pancreatic cancer.

Molecular basis for sunitinib efficacy and future clinical development.

P2888

s00280-012-1936-5

P304

547-553

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-012-1936-5

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1049288134

http://www.w3.org/2001/XMLSchema#string

P698

22868341

http://www.w3.org/2001/XMLSchema#string

P921

phase I clinical trial

P932

4199746

http://www.w3.org/2001/XMLSchema#string